Welcome to the 2023 Global Colorectal Cancer Congress

After an introduction to the 2023 Global Colorectal Congress from Candace Henley, M.P.H, C.P.N., Director of Equity and Partnerships at the Global Colon Cancer Association, keynote speaker Dr. Robert Winn talks about health disparities in cancer associated with location, local resources, urban vs. rural setting, and ethnicity. He discusses some of the structural factors behind these disparities. Dr. Winn emphasizes the importance of achieving equity in the distribution of scientific advancements in cancer care. He highlights some successes in reducing disparities while also acknowledging there is more to do to achieve equitable outcomes.

Keynote Address

The Importance of Health Equity in a Globalized World – A Brief Overview of the State of Global Health Disparities

Session 1

Reducing Colorectal Cancer Mortality – Matching Risk, Resources, and Strategy

Session 2

From Tissue to Terabytes: The Intersection of Pathology and Data Analytics in Colorectal Cancer

Dr. Phil Quirke discusses the use of data in maximizing the quality of surgical care in colorectal cancer, the resulting reductions in recurrence rate and mortality, and the disparities in receipt of optimal care. Dr. Quirke reviews some recent advances in colorectal cancer care, including the timing of chemotherapy and immunotherapy and deficient mismatch repair. Finally, Dr. Quirke reviews the use of artificial intelligence and machine learning in the pathology of colorectal cancer, and the need for validation of these A.I. algorithms in diverse populations around the world.

Session 3

Towards Health Equity: Palliative Care Is a Human Right, the Influence of Policy on Access & Availability and Imperative of the Global Call to Action

Session 4

Applying Innovation and Ethics in the Development and Application of Cancer Biomarkers to Achieve Global Health Equity

Dr. Alex Carlisle introduces cancer biomarkers, including several biomarkers specific to colorectal cancer, and then details the factors contributing to disparities in biomarker testing like lack of diverse representation in biomarker research and social determinants of health. He also addresses the phenomenon of transgenerational epigenetic inheritance. Dr. Carlisle then talks about the growth of artificial intelligence and machine learning in biomarker discovery and innovation, as well as how these data analytic tools can be used to reduce health disparities by incorporating the complex array of factors that contribute to health inequity.

Session 5

Strengthening Global Partnerships and Roadmap for the Future – Spotlight on 5 Recipients of CRC Health Equity Grants

Session 6

Community Education as a Tool to Improve Colorectal Cancer Survival

Dr. Elmer Huerta discusses community education strategies for cancer prevention and improving colorectal cancer survival worldwide. He details several guiding principles of community education including consistency, building trust, inclusion of a broad range of public health issues, and the use of all media channels available in a community. Dr. Huerta also describes his work with the Cancer Preventorium, a preventive care clinic driven by community education, and supported by patient navigation, including an example of a very successful clinic intervention to increase colorectal cancer screening uptake.

Session 7

Panel Discussion and Closing Remarks